Yvonne L. Greenstreet
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Yvonne L. Greenstreet
Yvonne L. Greenstreet is recorded as COO, CEO and Board Member at Alnylam Pharmaceuticals, Inc. (ALNY). The proxy statement of Alnylam Pharmaceuticals, Inc. reports total compensation of $14,867,600 for Yvonne L. Greenstreet in fiscal 2025, including a base salary of $1,404,200. Disclosed compensation is on record for 9 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-01-01–present
-
Current
2021-10-28–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Alnylam Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Yvonne Greenstreet CEO, COO
- Amy W. Schulman Chairman, Board Member
- Michael Bonney Chairman
- Michael W. Bonney Chairman
- Jeffrey Poulton CFO
- Manmeet S CFO
- Akshay K. Vaishnaw, M.D., Ph.D. CIO
- Benjamin F. Cravatt Board Member
- Benjamin F. Cravatt, Ph.D. Board Member
- Carolyn R. Bertozzi Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Executive Officer (principal executive officer) | $1,404,200 | $14,867,600 |
| 2024 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Executive Officer (principal executive officer) | $1,253,400 | $11,492,970 |
| 2023 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Executive Officer (principal executive officer) | $975,800 | $8,895,670 |
| 2022 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Executive Officer (principal executive officer) | $850,000 | $4,588,810 |
| 2021 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA Chief Executive Officer (principal executive officer) | $619,100 | $8,575,220 |
| 2020 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA Chief Executive Officer (principal executive officer) | $621,500 | $3,034,001 |
| 2019 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA President and Chief OperatingOfficer | $571,423 | $3,250,025 |
| 2018 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA President and Chief OperatingOfficer | $540,000 | $2,682,755 |
| 2017 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA ChiefOperating Officer | $504,200 | $984,674 |
Recent activity
No call appearances or filed executive changes recorded yet.